| Year |
Citation |
Score |
| 2021 |
Lubert AM, Alsaied T, Palermo JJ, Anwar N, Urbina EM, Brown NM, Alexander C, Almeneisi H, Wu F, Leventhal AR, Aldweib N, Mendelson M, Opotowsky AR. Fontan-Associated Dyslipidemia. Journal of the American Heart Association. e019578. PMID 33787283 DOI: 10.1161/JAHA.120.019578 |
0.455 |
|
| 2008 |
Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH, Williams KJ, Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1723-30. PMID 18669882 DOI: 10.1161/Atvbaha.108.173344 |
0.583 |
|
| 2004 |
Leventhal AR, Leslie CC, Tabas I. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking. The Journal of Biological Chemistry. 279: 8084-92. PMID 14638686 DOI: 10.1074/Jbc.M310672200 |
0.676 |
|
| 2001 |
Leventhal AR, Chen W, Tall AR, Tabas I. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. The Journal of Biological Chemistry. 276: 44976-83. PMID 11579092 DOI: 10.1074/Jbc.M106455200 |
0.631 |
|
| 2001 |
Chen W, Sun Y, Welch C, Gorelik A, Leventhal AR, Tabas I, Tall AR. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. The Journal of Biological Chemistry. 276: 43564-9. PMID 11559713 DOI: 10.1074/Jbc.M107938200 |
0.628 |
|
| 2000 |
Marathe S, Choi Y, Leventhal AR, Tabas I. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2607-13. PMID 11116060 DOI: 10.1161/01.Atv.20.12.2607 |
0.613 |
|
| Show low-probability matches. |